CytRx Picks Up Four Clinical-Stage Oncology Candidates With Innovive Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Biopharma separately plans additional toxicology tests for ALS candidate arimoclomal to address clinical hold imposed by FDA.